Long-wavelength ultraviolet A (340–400 nm UVA1) phototherapy has been reported to be
effective in atopic dermatitis, localized scleroderma and other T-cell-derived skin diseases …

Abstract Long-wavelength UVA (340–400 nm UVA-1) phototherapy has been reported to be
effective in atopic dermatitis, localized scleroderma and T-cell-derived skin diseases. We …

BACKGROUND AND OBJECTIVES: Standard or investigative immunosuppressive
therapies for cutaneous chronic graft-versus-host disease (GVHD) may prove not only …

Graft versus host disease (GVHD) is an important problem following allogenic bone marrow
transplantation (BMT). The beneficial effects of photochemotherapy with psoralens plus UVA …

Acute graft-versus-host disease (aGVHD) is a frequent and major complication after
allogeneic stem cell transplantation. For many years psoralen and ultraviolet (UV)-A light …

Graft versus host disease (GvHD) occurs in half the patients who receive allogenic
haematopoietic stem cell transplantation and is a major contributor for the morbidity and …

Narrowband ultraviolet B phototherapy (NB-UVB) is a therapeutic alternative for
haematopoietic stem cell transplantation-related skin graft-versus-host disease (GVHD). The …

BACKGROUND: Acute graft-versus-host disease (aGvHD) is a common complication of
allogeneic stem cell transplantation. It is usually treated with high doses of corticosteroids …

Background Graft‐versus‐host disease (GVHD) represents an important complication
following allogeneic bone marrow transplantation. In recent years, narrowband ultraviolet B …

Introduction and objectives Cutaneous chronic graft-vs-host disease (GVHD) is a common
complication of hematopoietic stem cell transplantation. Phototherapy is a therapeutic option …